Lacosamide

Details

Files

Generic Name:

Lacosamide

Project Status:

Complete

Therapeutic Area:

Epilepsy, partial onset seizures

Manufacturer:

UCB Canada Inc.

Call for patient/clinician input open:

October 25, 2010

Brand Name:

Vimpat

Project Line:

Reimbursement Review

Project Number:

SR0212-000

Call for patient/clinician input closed:

November 15, 2010

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Epilepsy, partial onset seizures (POS)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 25, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : October 25, 2010